“ANALYSIS OF UNFAVORABLE PROGNOSTIC FACTORS IN PATIENTS WHO RECEIVED HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL HEMOPOIETIC STEM CELLS TRANSPLANTATION FOR RELAPSES AND RESISTANT FORMS OF HODGKIN’’S LYMPHOMA”. Voprosy Onkologii, vol. 64, no. 3, Mar. 2018, pp. 414-8, https://doi.org/10.37469/0507-3758-2018-64-3-414-418.